Using magnetic stimulation to treat and prevent chronic migraines
Repetitive Transcranial Magnetic Stimulation in Treatment of Chronic Migraine
This study is testing whether a special magnetic treatment can help people with chronic migraines feel better and prevent future headaches.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06461767 on ClinicalTrials.gov |
What this trial studies
This study investigates the use of repetitive transcranial magnetic stimulation (rTMS) as a treatment and preventive measure for patients suffering from chronic migraines. It focuses on individuals who have not received any prophylactic treatment in the last three months. The approach aims to improve the quality of life and reduce headache-related disability associated with chronic migraines. Participants will be monitored regularly to assess the effectiveness of the intervention.
Who should consider this trial
Good fit: Ideal candidates are individuals diagnosed with chronic migraines who have not been on prophylactic treatment for the past three months.
Not a fit: Patients currently on prophylactic medications for chronic migraines or those with certain medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce the frequency and severity of chronic migraine attacks for patients.
How similar studies have performed: Previous studies have shown promising results with rTMS for migraine treatment, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * A study sample of patients with chronic migraine according to international classification of headache disorders-3 (ICHD-3). * Patients are regular on follow up visits. Exclusion criteria: * Patients with depression by Hamiliton scale of depression by using its Arabic version Translated by Dr Lotfy Fateem * patients on prophylactic medications for chronic migraine. * pregnancy. * cochlear implants, cardiac pacemaker, and metal body implanted in head-and-neck region. * Patients refused to give informed consent. * History of seizures.
Where this trial is running
Sohag
- Sohag faculty of medicine — Sohag, Egypt (Recruiting)
Study contacts
- Principal investigator: Tarek Mohamed — Sohag faculty of medicine
- Study coordinator: Tarek Mohamed
- Email: tarikmohamed@med.sohag.edu.eg
- Phone: 01025545002
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.